Pathophysiological explanation of cardiovascular benefits of sodium-glucose cotransporter-2 inhibitors by neurotrophic theory

被引：0
作者：
Hristova, Mariyana [1 ]
机构：
[1] Med Ctr Varna, Div Endocrinol, Varna, Bulgaria
来源：
MEDICAL HYPOTHESES | 2017年 / 102卷
关键词：
TYPE-2; DIABETES-MELLITUS; METABOLIC SYNDROME; SGLT2; INHIBITORS; BLOOD-PRESSURE; KIDNEY-DISEASE; HYPOTHESIS; OUTCOMES; DAPAGLIFLOZIN; REABSORPTION; METAANALYSIS;
D O I：
10.1016/j.mehy.2017.02.021
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页码：61 / 64
页数：4
相关论文
共 50 条
  • [31] Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Urolithiasis
    Anan, Go
    Kikuchi, Daisuke
    Hirose, Takuo
    Ito, Hiroki
    Nakayama, Shingo
    Mori, Takefumi
    KIDNEY INTERNATIONAL REPORTS, 2023, 8 (04): : 925 - 928
  • [32] Cardiovascular Protection With Sodium-Glucose Cotransporter-2 Inhibitors and Mineralocorticoid Receptor Antagonists in Chronic Kidney Disease A Milestone Achieved
    Sarafidis, Pantelis
    Papadopoulos, Christodoulos E.
    Kamperidis, Vasilios
    Giannakoulas, George
    Doumas, Michael
    HYPERTENSION, 2021, 77 (05) : 1442 - 1455
  • [33] Sodium-Glucose Cotransporter-2 Inhibitors in Vascular Biology: Cellular and Molecular Mechanisms
    Xiao, Lei
    Nie, Xin
    Cheng, Yanyan
    Wang, Nanping
    CARDIOVASCULAR DRUGS AND THERAPY, 2021, 35 (06) : 1253 - 1267
  • [34] Sodium-Glucose Cotransporter-2 Inhibitors: Lack of a Complete History Delays Diagnosis
    Leslie, Bruce R.
    Gerwin, Leslie E.
    Taylor, Simeon I.
    ANNALS OF INTERNAL MEDICINE, 2019, 171 (06) : 421 - +
  • [35] Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Water and Sodium Metabolism
    Tang, Jun
    Ye, Lifang
    Yan, Qiqi
    Zhang, Xin
    Wang, Lihong
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [36] Timing and Adherence Matter for Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure
    Yilmaz, Mehmet Birhan
    Celik, Ahmet
    Sahin, Anil
    Colluoglu, Tugce
    Ural, Dilek
    Kanik, Arzu
    Ata, Naim
    Ulgu, Mustafa Mahir
    Birinci, Suayip
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2025, 14 (07):
  • [37] Mechanisms of cardio-renal protection of sodium-glucose cotransporter-2 inhibitors
    Chiriaco, Martina
    Trico, Domenico
    Solini, Anna
    CURRENT OPINION IN PHARMACOLOGY, 2022, 66
  • [38] Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors: Harms or Unexpected Benefits?
    Andreea, Munteanu Madalina
    Surabhi, Swarnkar
    Razvan-Ionut, Popescu
    Lucia, Ciobotaru
    Camelia, Nicolae
    Emil, Tufanoiu
    Tiberiu, Nanea Ioan
    MEDICINA-LITHUANIA, 2023, 59 (04):
  • [39] Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular disease, death and safety outcomes in type 2 diabetes - A systematic review
    Radholm, Karin
    Wu, Jason H. Y.
    Wong, Muh Geot
    Foote, Celine
    Fulcher, Gregory
    Mahaffey, Kenneth W.
    Perkovic, Vlado
    Neal, Bruce
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 140 : 118 - 128
  • [40] Cardiovascular Disease Management With Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes: A Cardiology Primer
    Zhang, Allan
    Kalil, Ramsey
    Marzec, Alexander
    Coulter, Stephanie A.
    Virani, Salim
    Patel, Kershaw V.
    Segar, Matthew W.
    TEXAS HEART INSTITUTE JOURNAL, 2024, 51 (01)
12345